Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to recommend what might be recorded for atopic eczema patients in routine clinical care.
Objectives: Prioritize outcome domains to measure atopic eczema in clinical practice and select valid and practical outcome measurement instruments for the highest-priority domain.
Methods: An online survey of HOME members identified and ranked 21 possible health domains. Suitable instruments were then selected for the top-prioritized domain at the HOME VI meeting, using established consensus processes informed by systematic reviews of instrument quality.
Results: Patient-reported symptoms was the top-prioritized domain. In accordance with psychometric properties and feasibility, there was consensus that the recommended instruments to measure atopic eczema symptoms in clinical practice are the POEM, the PO-SCORAD index, or both. The numeric rating scale for itch received support pending definition and validation in atopic eczema.
Conclusion: Following the first step of the HOME Clinical Practice initiative, we endorse using the POEM, the PO-SCORAD index, or both for measuring atopic eczema symptoms in clinical practice. Additional high-priority domains for clinical practice will be assessed at subsequent HOME meetings.
Keywords: HOME; Harmonising Outcome Measures for Eczema; atopic dermatitis; atopic eczema; clinical practice; eczema; instruments; outcome measures; outcomes.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).Br J Dermatol. 2016 Jul;175(1):69-79. doi: 10.1111/bjd.14773. Epub 2016 Jul 19. Br J Dermatol. 2016. PMID: 27436240
Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.J Allergy Clin Immunol. 2013 Dec;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008. Epub 2013 Sep 12. J Allergy Clin Immunol. 2013. PMID: 24035157 Review.
Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.Allergy. 2017 Jan;72(1):146-163. doi: 10.1111/all.12959. Epub 2016 Jul 13. Allergy. 2017. PMID: 27322918 Review.
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.Br J Dermatol. 2017 Apr;176(4):979-984. doi: 10.1111/bjd.15179. Epub 2017 Mar 2. Br J Dermatol. 2017. PMID: 27858989 Review.
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.J Allergy Clin Immunol. 2014 Oct;134(4):800-7. doi: 10.1016/j.jaci.2014.07.043. J Allergy Clin Immunol. 2014. PMID: 25282560 Review.